HC Wainwright & Co. Initiates Coverage On Apyx Medical with Buy Rating, Announces Price Target of $7

Apyx Medical Corporation

Apyx Medical Corporation

APYX

0.00

HC Wainwright & Co. analyst Yi Chen initiates coverage on Apyx Medical (NASDAQ: APYX) with a Buy rating and announces Price Target of $7.